title: Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16.
abstract: Human papillomavirus (HPV) entry is accompanied by multiple receptor-induced conformational changes (CCs) affecting both the major and minor capsid proteins, L1 and L2. Interaction of heparan sulfate (HS) with L1 is essential for successful HPV16 entry. Recently, cocrystallization of HPV16 with heparin revealed four distinct binding sites. Here we characterize mutant HPV16 to delineate the role of engagement with HS binding sites during infectious internalization. Site 1 (Lys278, Lys361), which mediates primary binding, is sufficient to trigger an L2 CC, exposing the amino terminus. Site 2 (Lys54, Lys356) and site 3 (Asn57, Lys59, Lys442, Lys443) are engaged following primary attachment and are required for infectious entry. Site 2 mutant particles are efficiently internalized but fail to undergo an L1 CC on the cell surface and subsequent uncoating in the endocytic compartment. After initial attachment to the cell, site 3 mutants undergo L1 and L2 CCs and then accumulate on the extracellular matrix (ECM). We conclude that the induction of CCs following site 1 and site 2 interactions results in reduced affinity for the primary HS binding site(s) on the cell surface, which allows engagement with site 3. Taken together, our findings suggest that HS binding site engagement induces CCs that prepare the virus for downstream events, such as the exposure of secondary binding sites, CCs, transfer to the uptake receptor, and uncoating.
authors: Department of Microbiology and Immunology.
authors: Kathleen F
authors: KF
authors: Richards
authors: Malgorzata
authors: M
authors: Bienkowska-Haba
authors: Jhimli
authors: J
authors: Dasgupta
authors: Xiaojiang S
authors: XS
authors: Chen
authors: Martin
authors: M
authors: Sapp
mesh_terms: D001665:Binding Sites; D036022:Capsid Proteins / Q000235:genetics / Q000378:metabolism*; D002460:Cell Line; D004252:DNA Mutational Analysis; D006497:Heparan Sulfate / Q000378:metabolism*; D052162:Human papillomavirus 16 / Q000502:physiology*; D006801:Humans; D050505:Mutant Proteins / Q000235:genetics / Q000378:metabolism; D009856:Oncogene Proteins, Viral / Q000235:genetics / Q000378:metabolism*; D053586:Virus Internalization
chemical_list: D036022:Capsid Proteins; D006497:Heparan Sulfate; D050505:Mutant Proteins; D009856:Oncogene Proteins, Viral; C063316:L2 protein, Human papillomavirus type 16; C063317:L1 protein, Human papillomavirus type 16
references: J Virol. 2007 Oct;81(20):10970-80
references: 17686860
references: Virology. 2010 Nov 25;407(2):391-6
references: 20875908
references: PLoS Pathog. 2009 Jul;5(7):e1000524
references: 19629175
references: J Virol. 2001 Nov;75(21):10493-7
references: 11581419
references: Virology. 2003 Mar 1;307(1):1-11
references: 12667809
references: Virology. 2009 Feb 20;384(2):260-5
references: 19135222
references: PLoS Pathog. 2012 Feb;8(2):e1002519
references: 22346752
references: J Virol. 2004 Jan;78(2):751-7
references: 14694107
references: FEBS Lett. 2003 Feb 11;536(1-3):120-4
references: 12586349
references: J Virol. 2001 Feb;75(3):1565-70
references: 11152531
references: Biochem Biophys Res Commun. 2001 May 11;283(3):668-73
references: 11341777
references: PLoS One. 2008 Oct 02;3(10):e3313
references: 18836553
references: J Virol. 2003 Dec;77(24):12961-7
references: 14645552
references: Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6298-303
references: 20308582
references: Antiviral Res. 2002 Jul;55(1):117-27
references: 12076756
references: J Virol. 2003 Mar;77(6):3846-50
references: 12610160
references: J Gen Virol. 1994 Dec;75 ( Pt 12):3375-83
references: 7996132
references: J Virol. 2013 Mar;87(6):3435-46
references: 23302890
references: J Virol. 2007 Aug;81(16):8784-92
references: 17553881
references: J Virol. 1998 Mar;72(3):2160-7
references: 9499072
references: Virology. 2010 Jul 20;403(1):1-16
references: 20441998
references: J Biol Chem. 2007 Sep 21;282(38):27913-22
references: 17640876
references: PLoS Pathog. 2012;8(4):e1002657
references: 22536154
references: Mol Cell. 2000 Mar;5(3):557-67
references: 10882140
references: J Clin Virol. 2005 Mar;32 Suppl 1:S7-15
references: 15753007
references: J Biol Chem. 1998 Sep 25;273(39):24979-82
references: 9737951
references: J Virol. 2005 Mar;79(5):2839-46
references: 15709003
references: J Virol. 2012 Apr;86(8):4169-81
references: 22345461
references: J Virol. 2003 Nov;77(21):11625-32
references: 14557648
references: J Virol. 2003 Jun;77(11):6101-7
references: 12743267
references: J Virol. 1998 Jul;72(7):6186-9
references: 9621087
references: J Virol. 2003 Dec;77(24):13125-35
references: 14645569
references: J Virol. 2008 Oct;82(19):9505-12
references: 18667513
references: J Virol. 2013 Mar;87(5):2508-17
references: 23255786
references: Biophys J. 1991 Dec;60(6):1445-56
references: 1663794
references: J Virol. 1997 Mar;71(3):2449-56
references: 9032382
references: J Biol Chem. 1999 Feb 26;274(9):5810-22
references: 10026203
references: EMBO J. 2002 Sep 16;21(18):4754-62
references: 12234916
references: J Virol. 2007 Dec;81(24):13927-31
references: 17928339
references: J Virol. 2010 Oct;84(20):10661-70
references: 20702627
references: J Virol. 2008 Dec;82(24):12565-8
references: 18829767
references: Annu Rev Microbiol. 2002;56:677-702
references: 12142481
references: Virology. 2003 Jun 20;311(1):134-43
references: 12832211
references: J Virol. 2009 Mar;83(5):2067-74
references: 19073722
references: PLoS Pathog. 2011 Jul;7(7):e1002161
references: 21829355
references: J Virol. 2008 May;82(9):4638-46
references: 18305047
references: Virol J. 2006 Oct 02;3:83
references: 17014700
references: J Virol. 2001 Oct;75(19):9201-9
references: 11533183
references: J Virol. 2008 Jun;82(11):5190-7
references: 18367526
references: Int J Cancer. 2007 Aug 1;121(3):621-32
references: 17405118
references: J Biol Chem. 2011 Jan 28;286(4):2617-24
references: 21115492
references: J Med Virol. 2005 Jan;75(1):114-21
references: 15543569
references: PLoS One. 2012;7(8):e43519
references: 22927980
references: J Virol. 2012 Sep;86(18):9875-87
references: 22761365
references: Virology. 1996 Sep 1;223(1):174-84
references: 8806551
references: Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):73-8
references: 10618373
references: Virology. 1998 Apr 10;243(2):482-91
references: 9568045
references: Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1522-7
references: 16432208
references: J Clin Invest. 2001 Jul;108(2):169-73
references: 11457867
references: J Virol. 2013 Jul;87(13):7502-15
references: 23637395
references: Cell Microbiol. 2013 Nov;15(11):1818-36
references: 23601855
references: J Natl Cancer Inst. 1995 Jun 7;87(11):796-802
references: 7791229